When studying tumor tissue sections using multiplex tissue immunofluorescence, similar effects were substantiated showing CD137-mediated increases of CD3, CD8, and CD4 T cells that were reduced upon BV6 cotreatment (fig. The gene discussed is TNFRSF9; the disease is neoplasm.